The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator (Q40055054)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 August 2008
edit
Language Label Description Also known as
English
The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator
scientific article published on 27 August 2008

    Statements

    The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator (English)
    Karine Wiegler
    Christophe Bonny
    Didier Coquoz
    Lorenz Hirt
    27 August 2008
    360-366

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit